0000000000633419

AUTHOR

Mohsen Mazidi

showing 12 related works from this author

The association between coffee and caffeine consumption and renal function: insight from individual-level data, Mendelian randomization, and meta-ana…

2022

IntroductionBy applying on two-sample Mendelian randomization and systematic review and meta-analysis we investigated the association between caffeine and coffee intake with prevalent CKD and markers of renal function.Material and methodsFor the individual data analysis we analysed the NHANES data on renal function markers and caffeine intake. MR was implemented by using summary-level data from the largest ever GWAS conducted on coffee intake (N=91,462) and kidney function.ResultsFinally, we included the data of 18,436 participants, 6.9% had prevalent CKD (based on eGFR). Caffeine intake for general population was 131.1±1.1 mg. The percentage of participants with CKD, by caffeine quartile w…

Mendelian RandomizationChronic Kidney DiseaseGeneral MedicineCoffeeNHANES and Systematic Review
researchProduct

Impact of nutraceuticals on markers of systemic inflammation: Potential relevance to cardiovascular diseases - A position paper from the Internationa…

2021

Inflammation is a marker of arterial disease stemming from cholesterol-dependent to -independent molecular mechanisms. In recent years, the role of inflammation in atherogenesis has been underpinned by pharmacological approaches targeting systemic inflammation that have led to a significant reduction in cardiovascular disease (CVD) risk. Although the use of nutraceuticals to prevent CVD has largely focused on lipid-lowering (e.g, red-yeast rice and omega-3 fatty acids), there is growing interest and need, especially now in the time of coronavirus pandemic, in the use of nutraceuticals to reduce inflammatory markers, and potentially the inflammatory CVD burden, however, there is still not en…

RMArterial diseaseAnti-Inflammatory AgentsInflammationDiseaseC-reactive protein ; cardiovascular disease ; inflammation ; nutraceuticals ; omega-3 ; position paper ; red-yeast rice030204 cardiovascular system & hematologyBioinformaticsSystemic inflammationC-reactive protein03 medical and health sciences0302 clinical medicineNutraceuticalMedicineHumansPosition paper030212 general & internal medicineUncategorizedOmega-3InflammationbiologyC-reactive protein; Cardiovascular disease; Inflammation; Nutraceuticals; Omega-3; Position paper; Red-yeast rice; Anti-Inflammatory Agents; Biomarkers; Cardiovascular Diseases; Humans; Inflammation; Lipids; Dietary SupplementsVascular inflammationbusiness.industryC-reactive proteinC-reactive protein Cardiovascular disease Inflammation Nutraceuticals Omega-3 Position paper Red-yeast rice Anti-Inflammatory Agents Biomarkers Cardiovascular Diseases Humans Inflammation Lipids Dietary SupplementsCardiovascular diseaseRed-yeast riceLipidsCardiovascular DiseasesDietary Supplementsbiology.proteinPosition paperNutraceuticalsNutraceuticalmedicine.symptomCardiology and Cardiovascular MedicinebusinessBiomarkersProgress in cardiovascular diseases
researchProduct

Mapping geographical inequalities in oral rehydration therapy coverage in low-income and middle-income countries, 2000-17

2020

Background: Oral rehydration solution (ORS) is a form of oral rehydration therapy (ORT) for diarrhoea that has the potential to drastically reduce child mortality; yet, according to UNICEF estimates, less than half of children younger than 5 years with diarrhoea in low-income and middle-income countries (LMICs) received ORS in 2016. A variety of recommended home fluids (RHF) exist as alternative forms of ORT; however, it is unclear whether RHF prevent child mortality. Previous studies have shown considerable variation between countries in ORS and RHF use, but subnational variation is unknown. This study aims to produce high-resolution geospatial estimates of relative and absolute coverage o…

RJ101medicine.medical_treatmentCHILDRENZINC0302 clinical medicine030212 general & internal medicinemedia_commonGeographylcsh:Public aspects of medicine1. No povertyLow income and middle income countriesGeneral Medicine3142 Public health care science environmental and occupational health3. Good healthPeer reviewGeographyChild PreschoolA990 Medicine and Dentistry not elsewhere classifiedGeographical inequalities0605 MicrobiologyDiarrheaAFRICAInequalityDEATHSmedia_common.quotation_subject030231 tropical medicineDeveloping countryArticleRS1117 Public Health and Health Services03 medical and health sciencesMORBIDITYEnvironmental healthDIARRHEAL DISEASEmedicineHumansOral rehydration therapyHealthcare DisparitiesDeveloping CountriesModels StatisticalCHOLERAMORTALITYInfant NewbornInfantlcsh:RA1-1270Bayes TheoremMiddle incomeGLOBAL BURDENChild mortality0605 Microbiology 1117 Public Health and Health ServicesHealth Care SurveysITC-ISI-JOURNAL-ARTICLEFluid TherapyNAHuman medicineITC-GOLD
researchProduct

The global distribution of lymphatic filariasis, 2000–18:a geospatial analysis

2020

Background Lymphatic filariasis is a neglected tropical disease that can cause permanent disability through disruption of the lymphatic system. This disease is caused by parasitic filarial worms that are transmitted by mosquitos. Mass drug administration (MDA) of antihelmintics is recommended by WHO to eliminate lymphatic filariasis as a public health problem. This study aims to produce the first geospatial estimates of the global prevalence of lymphatic filariasis infection over time, to quantify progress towards elimination, and to identify geographical variation in distribution of infection. Methods A global dataset of georeferenced surveyed locations was used to model annual 2000–18 lym…

medicine.medical_specialtyGeospatial analysis030231 tropical medicineElephantiasis:ELIMINATIONcomputer.software_genreArticleLocal Burden of Disease 2019 Neglected Tropical Diseases Collaborators1117 Public Health and Health Services03 medical and health sciences0302 clinical medicineRA0421Environmental healthGlobal healthmedicine030212 general & internal medicineMass drug administrationLymphatic filariasisPublic healthlcsh:Public aspects of medicineTropical diseaselcsh:RA1-1270General Medicinemedicine.disease3. Good healthQRGeographyLymphatic systemITC-ISI-JOURNAL-ARTICLEA990 Medicine and Dentistry not elsewhere classifiedITC-GOLDcomputer0605 Microbiology
researchProduct

Mapping 123 million neonatal, infant and child deaths between 2000 and 2017

2019

Since 2000, many countries have achieved considerable success in improving child survival, but localized progress remains unclear. To inform efforts towards United Nations Sustainable Development Goal 3.2—to end preventable child deaths by 2030—we need consistently estimated data at the subnational level regarding child mortality rates and trends. Here we quantified, for the period 2000–2017, the subnational variation in mortality rates and number of deaths of neonates, infants and children under 5 years of age within 99 low- and middle-income countries using a geostatistical survival model. We estimated that 32% of children under 5 in these countries lived in districts that had attained ra…

SurvivalRJ101Mortalidad InfantilHBUNDER-5 MORTALITYGlobal HealthPediatrics0302 clinical medicine3123 Gynaecology and paediatricsChild deathInfant MortalityEpidemiologyGlobal healthMiddle income countryNacimiento vivo030212 general & internal medicine10. No inequalityChildPOPULATIONDeveloping worldeducation.field_of_studyPublic healthMultidisciplinaryGeographyMortality ratewa_9001. No povertyRSUCCESSPediatrikA900 Others in Medicine and Dentistry3142 Public health care science environmental and occupational health3. Good healthChild MortalityDeath childrenVACCINATIONHEALTHws_100INTERVENTIONSAFRICAmedicine.medical_specialtyUnited NationsGeneral Science & Technology030231 tropical medicinePopulationDeveloping countryArticleHealthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18]ITC-HYBRID03 medical and health sciencesAll institutes and research themes of the Radboud University Medical CenterSocial JusticeRecién nacidoNeonatal deathsmedicineSYSTEMATIC ANALYSISOrganizational ObjectivesHumanseducationDeveloping Countriesbusiness.industryPublic healthInfant NewbornInfantCIVIL REGISTRATIONPaediatricsChild survivalNewbornPREVENTIONMortality rateInfant mortalitywa_320ws_200Child mortalitySocioeconomic FactorsITC-ISI-JOURNAL-ARTICLEHuman medicinePaediatrics Public health Developing worldbusinessDemography
researchProduct

Mapping geographical inequalities in access to drinking water and sanitation facilities in low-income and middle-income countries, 2000-17.

2020

Background: Universal access to safe drinking water and sanitation facilities is an essential human right, recognised in the Sustainable Development Goals as crucial for preventing disease and improving human wellbeing. Comprehensive, high-resolution estimates are important to inform progress towards achieving this goal. We aimed to produce highresolution geospatial estimates of access to drinking water and sanitation facilities. Methods: We used a Bayesian geostatistical model and data from 600 sources across more than 88 low-income and middle-income countries (LMICs) to estimate access to drinking water and sanitation facilities on continuous continent-wide surfaces from 2000 to 2017, and…

Drinking water accessSanitationUniversal designGeographic MappingSocioeconomic FactorDISEASE0302 clinical medicineRA0421Hygiene11. SustainabilityGlobal health030212 general & internal medicineSanitationmedia_common2. Zero hungerPublic healthlcsh:Public aspects of medicine1. No povertyGeneral Medicine3142 Public health care science environmental and occupational health6. Clean waterLow-income countries3. Good healthA990 Medicine and Dentistry not elsewhere classifiedCHILD GROWTHTERRITORIESHYGIENEHuman0605 MicrobiologyDiarrheaAFRICAmedicine.medical_specialtymedia_common.quotation_subject030231 tropical medicineLocal Burden of Disease WaSH CollaboratorsDeveloping countryArticleGeographical inequalities1117 Public Health and Health Services12. Responsible consumptionDeveloping Countrie03 medical and health sciencesNUTRITIONAL INTERVENTIONSEnvironmental healthmedicineSYSTEMATIC ANALYSISHumansQUALITYSanitation/statistics & numerical dataOpen defecationImproved sanitationhand washingDeveloping CountriesModels StatisticalMiddle-income countriesDrinking WaterPublic healthlcsh:RA1-1270Bayes TheoremGLOBAL BURDENdiarrheal diseaseDIARRHEADiarrhea/epidemiologyLocal Burden of Disease WaSH CollaboratorSocioeconomic Factors0605 Microbiology 1117 Public Health and Health ServicesITC-ISI-JOURNAL-ARTICLEBusinessHuman medicineSanitation facilitiesITC-GOLD
researchProduct

Health effects of overweight and obesity in 195 countries over 25 years

2017

Source at: http://doi.org/10.1056/NEJMoa1614362 Background: Although the rising pandemic of obesity has received major attention in many countries, the effects of this attention on trends and the disease burden of obesity remain uncertain. Methods: We analyzed data from 68.5 million persons to assess the trends in the prevalence of overweight and obesity among children and adults between 1980 and 2015. Using the Global Burden of Disease study data and methods, we also quantified the burden of disease related to high body-mass index (BMI), according to age, sex, cause, and BMI in 195 countries between 1990 and 2015. Restults: In 2015, a total of 107.7 million children and 603.7 million adult…

MaleGerontologyPediatric ObesityobesityVDP::Medisinske Fag: 700::Helsefag: 800::Epidemiologi medisinsk og odontologisk statistikk: 803global healthDiseaseOverweightGlobal HealthVDP::Social science: 200::Demography: 300DISEASEVDP::Medical disciplines: 700::Health sciences: 800::Nutrition: 811Body Mass Index0302 clinical medicineRA0421PandemicPrevalenceadultsGlobal health030212 general & internal medicineChildhumansALL-CAUSE MORTALITYchildadult1. No povertypediatric obesity/epidemiology11 Medical And Health SciencesGeneral MedicineCANCER3. Good healthfemaleVDP::Medical disciplines: 700::Health sciences: 800::Epidemiology medical and dental statistics: 803Cardiovascular DiseasesCohortFemalemedicine.symptomLife Sciences & BiomedicineobesitatResearch ArticleAdultprevalenceoverweight/complications/epidemiologyWEIGHT-LOSS030209 endocrinology & metabolismKNEE OSTEOARTHRITISVDP::Samfunnsvitenskap: 200::Demografi: 300VDP::Medisinske Fag: 700::Helsefag: 800::Ernæring: 81103 medical and health sciencescardiovascular diseases/complications/mortalityMedicine General & InternalchildrenmaleGeneral & Internal MedicineEnvironmental healthmedicineHumansoverweightCOHORTObesityDisease burdenMETAANALYSISScience & TechnologyGBD 2015 Obesity Collaboratorsbusiness.industryADULTSOverweightmedicine.diseaseObesityPREVENTIONBODY-MASS INDEXCross-Sectional StudiesbusinessBody mass indexobesity/complications/*epidemiology
researchProduct

Association between phenotypic familial hypercholesterolaemia and telomere length in US adults: results from a multi-ethnic survey

2018

Aims: Familial hypercholesterolaemia (FH) accelerates atherosclerotic cardiovascular disease (ASCVD) and accordingly is the most potent hereditary cause of premature coronary heart disease. The association between telomere length (TL), a biological index of ageing, and FH has not been hitherto investigated. We addressed this question using data from the US National Health and Education National Surveys (NHANES, 1999-2002).Methods and results: We included individuals, who had TL measurements (with quantitative polymerase chain reaction method) and a phenotypic diagnosis of FH based on the Dutch Lipid Clinic Network (DLCN) criteria. Sample weights were applied for unequal probabilities of sel…

Malemedicine.medical_specialtyNational Health and Nutrition Examination SurveyCross-sectional studyPopulationFamilial hypercholesterolemia030204 cardiovascular system & hematologyHyperlipoproteinemia Type II03 medical and health sciences0302 clinical medicineInternal medicineMedicineHumans030212 general & internal medicineeducationNational Health and Education National Surveyseducation.field_of_studyTelomere lengthbusiness.industryMiddle AgedTelomeremedicine.diseaseNutrition SurveysObesityConfidence intervalUnited StatesCross-Sectional StudiesQuartileFemaleCardiology and Cardiovascular MedicinebusinessFamilial hypercholesterolaemiaBody mass indexEuropean Heart Journal
researchProduct

Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)

2023

Non-Alcoholic Fatty Liver Disease (NAFLD) is a common condition affecting around 10–25% of the general adult population, 15% of children, and even > 50% of individuals who have type 2 diabetes mellitus. It is a major cause of liver-related morbidity, and cardiovascular (CV) mortality is a common cause of death. In addition to being the initial step of irreversible alterations of the liver parenchyma causing cirrhosis, about 1/6 of those who develop NASH are at risk also developing CV disease (CVD). More recently the acronym MAFLD (Metabolic Associated Fatty Liver Disease) has been preferred by many European and US specialists, providing a clearer message on the metabolic etiology of the dis…

PharmacologySettore MED/04 - Patologia GeneraleNAFLDLiver steatosisPosition paperDietary supplements; Liver steatosis; NAFLD; Nutraceuticals; Position paper;NutraceuticalsDietary supplements
researchProduct

Predicting the environmental suitability for onchocerciasis in Africa as an aid to elimination planning

2021

Recent evidence suggests that, in some foci, elimination of onchocerciasis from Africa may be feasible with mass drug administration (MDA) of ivermectin. To achieve continental elimination of transmission, mapping surveys will need to be conducted across all implementation units (IUs) for which endemicity status is currently unknown. Using boosted regression tree models with optimised hyperparameter selection, we estimated environmental suitability for onchocerciasis at the 5 × 5-km resolution across Africa. In order to classify IUs that include locations that are environmentally suitable, we used receiver operating characteristic (ROC) analysis to identify an optimal threshold for suitabil…

OncocercosisDecision AnalysisRC955-962Onchocerciasislaw.inventionGeographical LocationsMedical Conditions0302 clinical medicinelawArctic medicine. Tropical medicineMedicine and Health Sciences030212 general & internal medicineOnchocerca11 Medical and Health SciencesData ManagementbiologyPharmaceuticswc_695Enfermedades ParasitariasOnchocerciasi3. Good healthInfectious DiseasesGeographyTransmission (mechanics)Helminth InfectionsEngineering and TechnologyMass Drug AdministrationOnchocercaPublic aspects of medicineRA1-1270Management EngineeringCartographyHumanResearch ArticleNeglected Tropical DiseasesComputer and Information SciencesDrug Administration030231 tropical medicineDecision treewa_395Dermatologywc_765Environmentwc_885Research and Analysis MethodsSkin Diseases03 medical and health sciencesDrug TherapySDG 3 - Good Health and Well-beingDiagnostic MedicineTropical MedicineParasitic DiseasesmedicineHumansDisease EradicationSpatial analysisIvermectinData collectionReceiver operating characteristicData VisualizationDecision TreesPublic Health Environmental and Occupational Health06 Biological SciencesOnchocerciasis ; Elimination planning ; Africa ; Implementation units ; Public healthTropical Diseasesmedicine.diseasebiology.organism_classificationHealth CareROC CurvePeople and PlacesAfricaHealth StatisticsMorbidityOnchocerciasisScale (map)ForecastingPLOS Neglected Tropical Diseases
researchProduct

Statin therapy in athletes and patients performing regular intense exercise - Position paper from the International Lipid Expert Panel (ILEP)

2020

Abstract Acute and chronic physical exercises may enhance the development of statin-related myopathy. In this context, the recent (2019) guidelines of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) for the management of dyslipidemias recommend that, although individuals with dyslipidemia should be advised to engage in regular moderate physical exercise (for at least 30 min daily), physicians should be alerted with regard to myopathy and creatine kinase (CK) elevation in statin-treated sport athletes. However it is worth emphasizing that abovementioned guidelines, previous and recent ESC/EAS consensus papers on adverse effects of statin therapy as wel…

0301 basic medicinemedicine.medical_specialtyConsensusSports medicineContext (language use)Physical exercise03 medical and health sciences0302 clinical medicineAthlethsMuscular DiseasesStatin intoleranceMedicineHumansAdverse effectAthlethExerciseMylagiaDyslipidemiasPharmacologybiologybusiness.industryAthletesExercisesAthleths Exercises Management Mylagia Statin intolerance.Athleths; Exercises; Management; Mylagia; Statin intolerancemedicine.diseasebiology.organism_classificationManagement030104 developmental biologyAthletes030220 oncology & carcinogenesisPhysical therapyPosition paperStatin therapyHydroxymethylglutaryl-CoA Reductase InhibitorsbusinessDyslipidemia
researchProduct

Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017

2020

Artículo con numerosos autores, sólo se mencionan el primero, los de la UAM y grupo colectivo

MaleLocal patternsDouble burdenBörnResearch & Experimental MedicineSjúkdómseinkenniDOUBLE BURDENChildhood overweightLífefnafræðiLæknisfræði0302 clinical medicineSyndemicChild11 Medical and Health Sciencesunder 5 years of ageGeneral Medicine3. Good healthGeographyMedicine Research & ExperimentalChild PreschoolIncomeGROWTHAFRICAmedicine.medical_specialtyBiochemistry & Molecular BiologyRJMedicinaImmunologyeducationMODELSwa_395General Biochemistry Genetics and Molecular BiologyArticleG03 medical and health sciencesHumansAuthor CorrectionDeveloping CountriesPovertyBiologyLBD Double Burden of Malnutrition CollaboratorsDemographyScience & TechnologyWasting SyndromePublic healthMORTALITYInfantNæringarskorturmedicine.diseaseObesityTRENDSsigns and symptomsSocial ClassRisk factorsSameindalíffræðiITC-ISI-JOURNAL-ARTICLEUNDERNUTRITIONHuman medicineClinical Medicine030217 neurology & neurosurgeryPediatric ObesityobesityOffitaÁhættuþættirGeographic MappingOverweightRA0421Global healthrisk factors030212 general & internal medicineSigns and symptomsWastingMalnutrition Global Burden of Diseases Global Nutrition low- and middle-income countries2. Zero hungerPublic health1. No povertyPublic Health Global Health Social Medicine and EpidemiologyA900 Others in Medicine and DentistryChildhood wastingPREVALENCEChemistryMappingFemaleLýðheilsamedicine.symptomLife Sciences & BiomedicineGROWTH FAILURENutritional StatusmalnutritionITC-HYBRIDws_115childrenEnvironmental healthmedicineErfðafræðiObesitywd_200MalnutritionInfant NewbornKlinisk medicinCell BiologyOverweightMalnutritionFolkhälsovetenskap global hälsa socialmedicin och epidemiologi3121 General medicine internal medicine and other clinical medicineNA
researchProduct